Alastair P. Greystoke

Freeman Road
Newcastle Upon Tyne, ENG NE77DN, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

The management of complex patients with inoperable stage III NSCLC: practical lessons from case-based discussion.

The management of complex patients with inoperable stage III NSCLC: practical lessons from case-based discussion.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 25, 2026

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

Journal: ESMO real world data and digital oncology

Published: April 20, 2026

Clinicians' Experiences of Implementing Clinical Frailty Scale Assessments in Lung Oncology Clinics: A Qualitative Interview Study.

Clinicians' Experiences of Implementing Clinical Frailty Scale Assessments in Lung Oncology Clinics: A Qualitative Interview Study.

Journal: Cancers

Published: January 21, 2026

Navigating controversies in stage III NSCLC: a multidisciplinary case discussion on evolving treatment paradigms.

Navigating controversies in stage III NSCLC: a multidisciplinary case discussion on evolving treatment paradigms.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 02, 2026

Sociodemographic inequalities in non-small cell lung cancer (NSCLC) novel treatments: a national population-based cohort study.

Sociodemographic inequalities in non-small cell lung cancer (NSCLC) novel treatments: a national population-based cohort study.

Journal: Journal of epidemiology and community health

Published: November 17, 2025

Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose.

Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose.

Journal: International journal of radiation oncology, biology, physics

Published: November 13, 2025

Sacubitril/Valsartan as a Cardiac Radioprotector.

Sacubitril/Valsartan as a Cardiac Radioprotector.

Journal: International journal of radiation oncology, biology, physics

Published: September 20, 2025

Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.

Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.

Journal: Cancer medicine

Published: August 04, 2025

Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors.

Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 01, 2025

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Journal: British journal of cancer

Published: June 18, 2025

Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study.

Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study.

Journal: Journal for immunotherapy of cancer

Published: June 16, 2025

Curative-Intent Multimodality Treatment for NSCLC: Will Global Healthcare Systems Rise to the Challenge? A Perspective From the United Kingdom.

Curative-Intent Multimodality Treatment for NSCLC: Will Global Healthcare Systems Rise to the Challenge? A Perspective From the United Kingdom.

Journal: JTO clinical and research reports

Published: May 16, 2025

Showing 1-12 of 112

Last Updated: 09/26/2026